Wells Fargo’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.24M Sell
18,002
-9,887
-35% -$3.27M ﹤0.01% 2623
2026
Q2
$9.34M Buy
27,889
+16,275
+140% +$5.15M ﹤0.01% 2245
2026
Q1
$3.74M Sell
11,614
-13,621
-54% -$4.21M ﹤0.01% 2821
2025
Q4
$7.44M Buy
25,235
+11,630
+85% +$2.17M ﹤0.01% 2299
2025
Q3
$721K Buy
13,605
+2,353
+21% +$114K ﹤0.01% 4038
2025
Q2
$473K Buy
11,252
+2,735
+32% +$104K ﹤0.01% 4184
2025
Q1
$323K Sell
8,517
-95
-1% -$5.93K ﹤0.01% 4380
2024
Q4
$663K Buy
8,612
+2,746
+47% +$199K ﹤0.01% 3993
2024
Q3
$338K Sell
5,866
-211
-3% -$11.4K ﹤0.01% 4249
2024
Q2
$251K Buy
6,077
+5,423
+829% +$256K ﹤0.01% 4357
2024
Q1
$39.9K Buy
654
+587
+876% +$26.3K ﹤0.01% 5346
2023
Q4
$1.49K Buy
67
+4
+6% +$72 ﹤0.01% 6144
2023
Q3
$1.6K Buy
63
+39
+163% +$738 ﹤0.01% 6126
2023
Q2
$416 Sell
24
-543
-96% -$8.31K ﹤0.01% 6528
2023
Q1
$6.88K Buy
+567
New +$23.9K ﹤0.01% 5968
2022
Q4
– Sell
-10
Closed – – 7653
2022
Q3
$0 Sell
10
-187
-95% -$9.32K ﹤0.01% 7197
2022
Q2
$7K Sell
197
-1
-0.5% -$107 ﹤0.01% 5899
2022
Q1
$31K Sell
198
-875
-82% -$180K ﹤0.01% 5856
2021
Q4
$318K Hold
1,073
– – ﹤0.01% 5023
2021
Q3
$28K Buy
102
+90
+750% +$24.4K ﹤0.01% 5869
2021
Q2
$3K Sell
12
-109
-90% -$39K ﹤0.01% 6493
2021
Q1
$59K Sell
121
-261
-68% -$186K ﹤0.01% 5741
2020
Q4
$315K Buy
+382
New +$223K ﹤0.01% 4852

Other funds holding PRAX

Wells Fargo's PRAX Position: Q3 2026 in Review

Wells Fargo reduced its Praxis Precision Medicines (PRAX) stake by 35% in Q3 2026, selling an estimated $3.27M and leaving 18,002 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2623.

Wells Fargo first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. The position peaked at $9.34M in Q2 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Wells Fargo held 18,002 shares of Praxis Precision Medicines worth $5.24M as of Q3 2026.
  • Wells Fargo sold 9,887 Praxis Precision Medicines shares in Q3 2026, an estimated $3.27M.
  • Praxis Precision Medicines made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #2623 holding.
  • Wells Fargo first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • Wells Fargo's Praxis Precision Medicines position peaked at $9.34M in Q2 2026.
  • 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.